Publication of new guidance document on procedures for authorising medicinal products during a pandemic
Befristete Bewilligung zum Vertrieb in schweizerisch/österreichische Aufmachung
Media articles on Echinaforce® and online offers in the context of the COVID-19 pandemic
Licences in accordance with art. 22 para. 3 of the COVID 19 Ordinance 3
Befristete Bewilligung zum Vertrieb in spanischer Aufmachung
Swissmedic is issuing an urgent warning regarding slimming products and other supposedly natural products
Falsified Soliris 300 mg, batch 1000706, EXP. 07/2021 (The Swiss market is not affected)
Information sheet on protective masks, gloves and other personal protective equipment as well as hand sanitisers and coronavirus tests
Information on the new coronavirus (SARS-CoV-2)
Information concerning the new EU-Regulations as well as their implementation in Switzerland.
Communications regarding the safety of medicines
Product groups, services
Stay up to date
Our news subscription service provides on-going information via e-mail.
Reporting undesirable effects
Reporting incidents & FSCAs
The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019
What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.
Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.
Swissmedic, Swiss Agency for Therapeutic Products
Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.
For further information...